Latest Series A Funding Rounds
Companies raising their first major institutional growth round, from the product they sell to the investors backing their next stage.
- Rounds
- 872 All time
- Disclosed funding
- $32.9B 788 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| E Builds talent pipelines for roles AI can't replace | $30M | Series A | Healthtech | India | Investors | |
| CT Caldera TherapeuticsCompany profile Develops bispecific antibody CLD-423 for inflammatory bowel disease Develops bispecific antibody CLD-423 for inflammatory bowel disease | $37.5M | Series A1Series A | Biotech | United States | Investors | |
| d depthfirstCompany profile Develops AI-native security platform for software vulnerability detection and fix recommendations Develops AI-native security platform for software vulnerability detection and fix recommendations | $40M | Series A | Cybersecurity | United States | Investors | |
| PE Project ElevenCompany profile Builds tools for post-quantum security and migration for digital assets Builds tools for post-quantum security and migration for digital assets | $20M | Series A | Fintech | United States | Investors | |
| W WeatherPromiseCompany profile Provides weather guarantees and refunds for trips if weather is worse than promised Provides weather guarantees and refunds for trips if weather is worse than promised | $12.8M | Series A | Travel tech | United States | Investors | |
| RL Develops AI operating system for oncology workflows | $11.1M | Series A | AI | United States | Investors | |
| VO Vivere OncotherapiesCompany profile Vivere Oncotherapies develops cancer treatments designed to activate immune recognition and destruction of cancer cells. Vivere Oncotherapies develops cancer treatments designed to activate immune recognition and destruction of cancer cells. | $10M | Series A | Biotech | United States | Investors | |
| K Provides payments platform for restaurants, bars, and clubs | €12M | Series A | Fintech | — | Investors | |
| N NetBird develops an open-source Zero Trust network-security platform. | $10M | Series A | Cybersecurity | Germany | Investors | |
| CB AI platform for accelerated drug discovery and development | $25M | Series A | AI | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Y Combinator (YC)
Clueso, Santé, Flai
52rounds0led - 2Andreessen Horowitz (a16z)
Eka Robotics, TypeSafe AI, Sharp Performance
29rounds9led - 3General Catalyst
Baba, Melius, Disha (formerly Curelink)
24rounds1led - 4Lightspeed
Warp Sciences, Zenzap, Avarra
21rounds4led - 5Alumni Ventures
Chariot Claims, RegCell, Inc., Lightfield
21rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.